Worldwide distributor of NSN parts and consumables located in the USA.
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Phosphates, nesoi (excluding triammonium & trisodium)
Phosphates, n.E.S.
Chemicals-inorganic
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
ESDA - No known electrostatic discharge (esd) or electromagnetic interference (emi) sensitivity.
ADPE- Represents items with no adp components
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
043940 - Chemicals noi
635 - Chemicals, other than drugs or sundries
9 - Other or no special handling required (sh)
A - Shipment is not a consolidation and does not exceed 84 inches in any dimension.
C - Chemical corps items and all other chemicals not covered in other classificatons. note: when an item has a chemical proper shipp
W - Rating variable
Z - No special type of cargo code applicable
Questions & Answers: |
|
What are the historical prices recorded for this stock number? | |
Historical data shows pricing from $323.39 to $538.99.. | |
Does NSN 6810-01-481-6872 have a shelf life? | |
No. There is no shelf life applicable for this NSN. | |
What NATO entities are users of this NSN? | |
U.s. Marine Corps, and Department Of The Navy | |
What is the NIIN of NSN 6810-01-481-6872? | |
014816872 or 01-481-6872 | |
Does NSN 6810-01-481-6872 require demilitarization? | |
Yes - ITAR Controlled | |
What is the most recent solicitation for NSN 6810-01-481-6872? | |
No solicitations for this NSN. | |
When was this national stock number assigned to the federal catalog? | |
Jan 19, 2001 |
Ld50 lc50 mixture: no data provided by manufacturer
health hazards acute and chronic: inhalation: no known risk of
overexposure. Ingestion: ingestion of calciquest may cause nausea.
ingestion of calciquest as recommended in potable water presents no
known risk of overexposure. Skin: po ssible irritation of exposed
tissue due to individual sensitivity. Eye: possible irritation to
eyes if exposed to calciquest due to individual sensitivity.
explanation of carcinogenicity: no data provided by manufacturer
effects of overexposure: inhalation: no known risk of overexposure.
ingestion: ingestion of calciquest may cause nausea. Ingestion of
calciquest as recommended in potable water presents no known risk
of overexposure. Skin: po ssible irritation of exposed tissue due
to individual sensitivity. Eye: possible irritation to eyes if
exposed to calciquest due to individual sensitivity.
medical cond aggravated by exposure: no data provided by manufacturer
First aid: calciquest is not a hazardous substance under osha or dot
regulations, nor a hazardous waste to the epa. Any symptoms of
discomfort should be treated symptomatically. Victim should be
removed from env ironment or wash exposed tissue in cool, flowing
water for 15 minutes. Medical attention is needed only if symptoms
persist following first aid.
Hcc: n1
boiling pt: =104.4c, 220.F
solubility in water: 100%
appearance and odor: white powder - odorless
Stability indicator/materials to avoid: yes
none. It is good industrial practice to be careful when handling all
mixtures with strong oxidizers or reducing agents
stability condition to avoid: none
hazardous decomposition products: none
conditions to avoid polymerization: will not occur
Waste disposal methods: sanitary sewer
Ingred name: sodium hexametaphosphate
cas: 68915-31-1
rtecs #: tr4950250
Ld50 lc50 mixture: oral, rat, ld50: 8,600 mg/kg
health hazards acute and chronic: no significiant hazards associated
with this material. Eye contact: no more than slightly irritating
based on toxicity studies. The dry material may cause foreign body
irritation on some individuals. skin contact: no more than
slightly toxic or slightly irritating based on toxicity studies.
prolonged contact with the dry material may cause drying or
chapping of the skin. Inhalation: inhalation of the dust may cause
coughing and sneezing. Ingestion: not toxic if swallowed based on
toxicity studies. No significant adverse health effects are
expected if only small amounts (less than a mouthful) a re
swallowed.
effects of overexposure: eye contact: irritatation. Skin contact:
irritation, drying or chapping of skin. Inhalation: coughing and
sneezing. Ingestion: no adverse health effects expected if only
small amounts (less than a mou thful) are swallowed.
First aid: if in eyes or on skin: immediate first aid is not likely to
be required. However, this material can be removed with water.
remove material from eyes, skin and clothing. Wash heavily
contaminated cloth ing before reuse. If inhaled: immediate first
aid is not likely to be required. However, if symptoms occur,
remove to fresh air. If swallowed: immediate first aid is not
likely to be required. A physi cian or poison control center can be
contacted for advice.
Hcc: n1
melt/freeze pt: =628.C, ######f
spec gravity: powder: 78-84 lb/ft3
ph: 7.0 (as 1% sol)
solubility in water: infinitely soluble
appearance and odor: white powder, granules, or glass plates, no odor.
Stability indicator/materials to avoid: yes
none known.
stability condition to avoid: solutions of this product will hydrolyze
to form ortho phosphate and other shorter chain phosphates.
dissolution is impacted by termperature and ph of the system.
hazardous decomposition products: none known.
conditions to avoid polymerization: will not occur.
Waste disposal methods: this material when discarded is not a hazardous
waste as that term is defined by the resource conservation and
recovery act (rcra), 40 cfr 261. Dry material may be landfilled or
recycled in accordance with local, state and federal regulations.
consult your attorney or appropriate regulatory official s for
information on such disposal.
Ingred name: sodium hexametaphosphate
cas: 68915-31-1
rtecs #: tr4950250
= wt: 100.
osha pel: 15 mg/m3(t dust)8hr
acgih tlv: 19 mg/m3(inhal)8hr